End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,250 KRW | -3.85% | -10.81% | +23.13% |
Business Summary
Number of employees: 548
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 179,676 | 100.0 % | 196,346 | 100.0 % | +9.28% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 179,676 | 100.0 % | 196,346 | 100.0 % | +9.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Jin Kim
CEO | Chief Executive Officer | 59 | - |
Seung-Bum Heo
CEO | Chief Executive Officer | 42 | - |
Cheong-Ha Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Joon-Beom Huh
BRD | Director/Board Member | 39 | - |
Kyung-Chul Oh
BRD | Director/Board Member | 59 | - |
Hwan-Sam Yong
SAM | Sales & Marketing | 48 | - |
Byeong-Ik Han
SAM | Sales & Marketing | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seung-Bum Heo
CEO | Chief Executive Officer | 42 | - |
Kyung-Chul Oh
BRD | Director/Board Member | 59 | - |
Joon-Beom Huh
BRD | Director/Board Member | 39 | - |
Sang-Jin Kim
CEO | Chief Executive Officer | 59 | - |
Hyung-Seok Choi
BRD | Director/Board Member | 60 | - |
Chang-Ho Kim
BRD | Director/Board Member | 52 | - |
Hyung-Wook Kim
BRD | Director/Board Member | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,569,717 | 12,859,220 ( 62.52 %) | 462,158 ( 2.247 %) | 62.52 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
761,373 | 3.83% | 5,084,632 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+23.13% | 122M | |
+16.40% | 42.95B | |
+16.32% | 21.38B | |
+19.70% | 15.05B | |
+18.64% | 14.45B | |
+53.58% | 13.04B | |
-0.05% | 6.79B | |
-12.64% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- A000520 Stock
- Company Samil Pharmaceutical Co.,Ltd